<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To estimate the association of endogenous levels of bioavailable <z:chebi fb="51" ids="17347">testosterone</z:chebi> and <z:chebi fb="1" ids="23965">estradiol</z:chebi> with risk for <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> and <z:hpo ids='HP_0000726'>dementia</z:hpo> in old men </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Within the population-based, prospective Honolulu-Asia Aging Study, 2,974 men, aged 71 to 93 years, without <z:hpo ids='HP_0000726'>dementia</z:hpo> were reexamined 3 times over an average of 6 years for development of <z:hpo ids='HP_0000726'>dementia</z:hpo> and <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0001268'>Cognitive decline</z:hpo> was measured with the Cognitive Abilities Screening Instrument </plain></SENT>
<SENT sid="3" pm="."><plain>Incident <z:hpo ids='HP_0000726'>dementia</z:hpo> was diagnosed according to standard criteria </plain></SENT>
<SENT sid="4" pm="."><plain>A total of 134 men experienced development of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD; including 40 cases with contributing cerebrovascular disease) and 44 experienced development of vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Adjusting for age and other covariates, <z:chebi fb="51" ids="17347">testosterone</z:chebi> was not associated with risk for <z:hpo ids='HP_0000726'>dementia</z:hpo> (using Cox regression analyses) or <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> (using random coefficient analyses) </plain></SENT>
<SENT sid="6" pm="."><plain>However, higher levels of <z:chebi fb="1" ids="23965">estradiol</z:chebi> were associated with risk for AD (hazard ratio per standard deviation increase, 1.25; 95% confidence interval, 1.05-1.47) and AD with cerebrovascular disease (hazard ratio, 1.19; 95% confidence interval, 1.02-1.38) </plain></SENT>
<SENT sid="7" pm="."><plain>Also, compared with the lowest tertile of <z:chebi fb="1" ids="23965">estradiol</z:chebi>, men in the middle and highest tertile of <z:chebi fb="1" ids="23965">estradiol</z:chebi> had 0.24 and 0.28 points lower Cognitive Abilities Screening Instrument scores, respectively, for each year increase in age </plain></SENT>
<SENT sid="8" pm="."><plain>INTERPRETATION: In old men, endogenous <z:chebi fb="51" ids="17347">testosterone</z:chebi> levels are not associated with risk for <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> and AD, whereas higher <z:chebi fb="0" ids="50114">estrogen</z:chebi> levels increase risk for <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> and AD </plain></SENT>
</text></document>